Canadian Cancer Society shared a post on LinkedIn:
“Call for applications!
The Canadian Cancer Society is proud to be the founding partner of Creative Destruction Lab innovate program: CDL Cancer.
This program provides early-stage companies commercializing cancer research access to world-class mentorship in clinical development, business development, go-to-market, and financing strategies.
The program:
- Matches founders with experienced entrepreneurs, clinicians, investors, and scientists
- Is a non-profit, with zero fees or equity required to participate
- Helps teams triage and accomplish sprint-style business objectives
- Closes the gap between invention and impact
Applications to join the 2026-2027 CDL Cancer cohort are currently being accepted until July 24, 2026. ”
Other articles about Canadian Cancer Society on OncoDaily.